This week: in COVID-19 related news, a heartburn medication shows benefits; Bebtelovimab is authorized; Veklury is shown to retain antiviral activity against variants. And away from COVID, a functionally scored carbidopa/levodopa tablet is now available for Parkinson disease, and the FDA issues an alert regarding ketamine compounding.